Oncotarget: Table of Contents - Volume 12, Issue 21
Channel: Oncotarget
Date: 12/10/2021

View the latest oncology-focused research published in this week’s issue of Oncotarget, Volume 12, Issue 21.
https://www.oncotarget.com/archive/v12/i21/

Priority Research Paper (Cover) - “ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide” 
https://doi.org/10.18632/oncotarget.28090

Research Paper - “Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumab” 
https://doi.org/10.18632/oncotarget.28086 

Research Paper - “Luminescence complementation technology for the identification of MYC:TRRAP inhibitors” 
https://doi.org/10.18632/oncotarget.28078

Research Paper - “TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan” https://doi.org/10.18632/oncotarget.28073

Research Paper - “The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey” https://doi.org/10.18632/oncotarget.28076

Research Paper - “Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma” 
https://doi.org/10.18632/oncotarget.28069

Research Paper - “Trends in oligomannosylation and α1,2-mannosidase expression in human cancers” https://doi.org/10.18632/oncotarget.28064

Research Paper - “TP53 mutations determined by targeted NGS in breast cancer: a case-control study” https://doi.org/10.18632/oncotarget.28071

Research Paper - “Association of four genetic variants with colorectal cancer in Kazakhstan population” https://doi.org/10.18632/oncotarget.28070

Editorial - “Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?”
https://doi.org/10.18632/oncotarget.27987 (PDF Download)

Research Perspective - “Neddylation and anti-tumor immunity” 
https://doi.org/10.18632/oncotarget.28019

Keywords - ATR, cancer immunotherapy, drug discovery, comprehensive genomic profiling, glioblastoma, oligomannose, TP53 mutations, head and neck cancer, neddylation, breast cancer, colorectal cancer, multiple myeloma (MM), cancer, science, research, oncology

About Oncotarget

Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. 

To learn more about Oncotarget, please visit https://www.oncotarget.com/ or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/oncotargetyoutube
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget

Oncotarget is published by Impact Journals, LLC. Please visit https://www.impactjournals.com/ or connect with @ImpactJrnls

Media Contact
MEDIA@IMPACTJOURNALS.COM
18009220957